Biotech organizations sit at the center of scientific innovation, but many continue to operate without a clear understanding of their own environmental footprint. Laboratories generate huge volumes of data every day, spanning experiments, procurement, facilities operations, supply chains, digital systems, and waste handling. Yet most of this information remains unused, inaccessible, or disconnected from decision-making. The result is a sector that is data rich but insight poor. This gap limits scientific efficiency, slows down optimization, and prevents organizations from identifying the most meaningful opportunities to reduce environmental impact.
The central argument of this article is simple. Biotech companies already have the data they need to improve sustainability. They simply don’t analyze it effectively. Resource usage, experimental variability, energy consumption, waste streams, instrument utilization, and procurement patterns are all measurable today. The issue isn’t access to data – it’s making use of what already exists across labs and manufacturing.
The data paradox in biotech
Biotech’s struggle to extract value from data has several systemic causes. The first is fragmentation. Experimental results, operational data, procurement records, and sustainability metrics are often stored in different systems that do not communicate. Scientific data may sit in an ELN, process data in a LIMS or MES, and environmental data in facilities management systems. Manufacturing energy use, HVAC load, sterilization energy, waste inactivation, waste disposal costs, and cleanroom operational data are commonly held by engineering teams rather than scientists. None of these datasets are inherently difficult to use, but their separation makes holistic analysis almost impossible.
Metadata quality is another issue. Even when data is captured digitally, experiments may be described inconsistently, units may vary between groups, and fields may be left blank. That makes aggregation, comparison, or modelling difficult. Without shared standards, data stays locked in the context it was generated.
And then there’s culture. Most biotech companies still treat data as a by-product of experiments or operations rather than as an asset in its own right. Scientists understandably focus on biological outcomes, while procurement teams focus on budgets, and sustainability teams focus on reporting. Rarely do these groups come together to analyze patterns that span all three domains. When data is not viewed as strategic, it is not stewarded with long-term value in mind.
What biotech’s existing data already shows
These challenges create a paradox. Biotech generates more data than almost any other industry, yet many companies still struggle to answer basic questions about their environmental performance: Which assays consume the most plastics? Which workflows drive repeat experiments? Which manufacturing steps use the most energy? Which consumables produce the greatest volume of regulated waste? Which equipment runs continuously despite intermittent demand? Which deviations or failures are linked to high scrap rates? All of this information exists, but it is rarely consolidated into a useful picture.
Start interpreting that data, and patterns in resource use quickly emerge. For example, analysis of consumables per assay or per campaign often shows that a small number of screening steps account for the majority of plastic use. In manufacturing, HVAC systems in controlled environments contribute heavily to total energy consumption, yet visibility into real use is often limited. Waste inactivation and disposal volumes follow predictable patterns, but workflows that drive these loads remain poorly characterized.
Instrument utilization data reveals additional opportunities. Many devices draw substantial energy even when idle. Scheduling patterns, overnight operation, and maintenance cycles influence total energy use. Facilities may run continuous HVAC for rooms that do not require it. Without analyzing these datasets, optimization remains out of reach.
Reproducibility is another hidden sustainability lever. Failed experiments consume additional materials, energy, and time. Patterns in reproducibility issues are detectable, but only if results and metadata are structured and accessible.
Redesigning workflows through operational insight
Once these patterns become visible, organizations can redesign laboratory and manufacturing processes to reduce environmental impact without limiting scientific output. Workflows with high plastic intensity can be consolidated or restructured. Assay formats can be standardized across teams to reduce variability. Screening cascades can be adjusted to minimize redundant confirmation steps. In manufacturing, HVAC schedules can reflect real occupancy and process timing. Waste inactivation loads can be levelled to reduce peak energy demand. Analytical and cell culture instruments can be shifted to low energy modes during predictable idle periods. Repetitive manual steps that contribute to deviations can be replaced with more reliable alternatives.
These examples illustrate a broader principle. Sustainability emerges naturally when workflows are informed by evidence rather than habit.
Connecting laboratory data with procurement and sustainability decisions
Operational data becomes even more powerful when linked with procurement. Many organizations estimate consumable needs rather than basing decisions on actual usage patterns. Data analysis often reveals over-ordering, under-ordering, and unexpected demand spikes. Procurement teams can identify which materials would produce meaningful environmental improvements if substituted, and which categories dominate usage volume. Supplier evaluation can incorporate environmental metrics, especially when LCA values are available for comparison. For items used at scale, even small per-unit improvements accumulate into substantial reductions in total footprint.
Environmental sustainability becomes quantifiable only when consumption histories, process data, and procurement records are viewed together.
Why biotech still fails to capture value from its data
Despite these opportunities, many organizations still fall short. Most digital systems were designed to satisfy compliance, not optimization. ELN and LIMS platforms typically focus on documentation rather than analytics. MES systems emphasize execution rather than modelling or prediction. Facilities systems track energy and waste but seldom feed insights back into scientific workflows.
Teams also lack incentives for complete or well-structured data capture. Metadata entry is often viewed as administrative overhead rather than a foundation for future decision-making. Scientists are rarely given training in data literacy. Data specialists may not be embedded within operational teams. Sustainability teams often sit outside scientific and procurement functions and therefore lack direct access to meaningful operational datasets.
Adopting practices from digital-native sectors
Digital-native industries treat data as a designed product with ownership, governance, and long-term value. Biotech can adopt similar practices without excessive complexity. Experimental templates can include minimum metadata fields. Scientific, operational, and facilities data can be structured with consistent taxonomies. Cross-functional dashboards can present indicators for operational efficiency and environmental impact. Data pipelines can be maintained to ensure that information remains usable over time.
These practices create conditions where insight generation becomes routine rather than exceptional.
A path toward sustainability by design
Creating a sustainability-by-design data ecosystem requires coordinated changes across the organization. Experimental planning tools can integrate environmental considerations alongside scientific objectives. Digital systems such as ELN, LIMS, and MES can include fields that capture consumable use, energy-intensive steps, or expected waste streams. Procurement decisions can incorporate environmental performance metrics. Sustainability teams can work with data engineers to translate existing datasets into actionable insights. When environmental metrics are embedded into everyday workflows, sustainability becomes part of operational excellence rather than a separate initiative.
None of this requires additional experimental work. It requires a shift in how organizations structure, view, and use the data they already have.
Conclusion: the data you need is already there
Biotech’s environmental footprint is shaped less by overarching strategies and more by thousands of decisions made each day in laboratories and manufacturing suites. Each decision consumes materials, energy, and time. By analyzing the data already generated, organizations can understand these decisions at scale, identify opportunities for reducing waste, and implement responsible improvements that strengthen both scientific and environmental performance.
Biotech does not lack data. It lacks the consistent habit of using data. Sustainability by design is achievable, and the path begins with unlocking the value hidden in ordinary operations.
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
